62 results
6-K
EX-99.1
GMVDF
G Medical Innovations Holdings Ltd.
25 Aug 23
Report of Foreign Private Issuer
8:37am
commented “while we regret the delisting of our shares from Nasdaq, we remain confident in the long term growth and success of the Company. We will work … intention to quote its shares and warrants on the OTCQB or OTCQX, when it discusses the Company’s long term growth and success, when it discusses
F-1
GMVDF
G Medical Innovations Holdings Ltd.
27 Jul 23
Registration statement (foreign)
4:47pm
quarter of 2023, the Panel will decide if we demonstrated an ability to maintain compliance with the continued listing requirements on a long-term basis … and cash equivalents
Total assets
Long term debt
Accumulated deficit
Total shareholders’ equity (deficit)
As of July 23, 2023, we had approximately $1.1
6-K
EX-99.1
GMVDF
G Medical Innovations Holdings Ltd.
16 May 23
G Medical Innovations Holdings Ltd. Announces Receipt of Nasdaq Hearings Panel’s Decision to Grant Exception for Continued Listing
8:00am
requirements on a long-term basis. In addition, from May 11, 2023 until the end of the Exception Period, the Panel reserves the right to reconsider … of 2023 the Panel will decide if the Company has demonstrated an ability to maintain compliance with Nasdaq requirements on a long-term basis
424B4
GMVDF
G Medical Innovations Holdings Ltd.
4 Apr 23
Prospectus supplement with pricing info
12:13pm
:
Cash and cash equivalents
Total assets
Long term debt
Accumulated deficit
Total shareholders’ equity (deficit)
As adjusted data gives effect … may have a negative effect on us over the short or long term. Previously, to cope with high inflation and financial imbalances, the Chinese government
6-K
EX-99.1
3ojosi74kbguf97a4l
18 Nov 22
Report of Foreign Private Issuer
5:25pm
6-K
EX-99.2
z7wjwxk9vv4vjyh
27 Oct 22
Securities Purchase Agreement
4:44pm
424B5
pqqfwdrob2c 5hyn
19 Sep 22
Prospectus supplement for primary offering
6:49am
6-K
EX-10.1
3th7k8xt1o0lt30g
19 Sep 22
Report of Foreign Private Issuer
6:04am
POS AM
37s uif5qmpnd
13 Jul 22
Prospectus update (post-effective amendment)
1:05pm
POS AM
jy55f vrmwie5iafe
13 Jul 22
Prospectus update (post-effective amendment)
1:03pm
F-3
EX-10.1
69drnzi
11 Jul 22
Shelf registration (foreign)
4:42pm
F-3
75fo22w3d8 7wxi8
11 Jul 22
Shelf registration (foreign)
4:42pm
F-1
eexoztdewws0nl
19 May 22
Registration statement (foreign)
5:21pm
20-F
0nz0xxc
29 Apr 22
Annual report (foreign)
12:00am
F-1/A
gltbm8s
15 Feb 22
Registration statement (foreign) (amended)
4:02pm
F-1
8sqm9lh
14 Feb 22
Registration statement (foreign)
5:22pm
F-1
bigcy943u5ntrt
31 Jan 22
Registration statement (foreign)
10:32am
6-K
EX-99.1
gh9wt3sql56l
27 Jan 22
G Medical Innovations Joins Forces with Serology Covid Testing to
5:23pm
6-K
EX-99.1
2tfb8ur7de452lx6da
15 Sep 21
Report of Foreign Private Issuer
4:01pm